- Facultat de Medicina
Centre
![Foto de - Facultat de Medicina](/img/noimage.png)
![Foto de Hospital Duran i Reynals](/img/noimage_org.png)
Hospital Duran i Reynals
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Duran i Reynals (20)
2024
-
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Haematologica, Vol. 109, Núm. 2, pp. 543-552
2022
-
Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy
Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258
-
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
Blood Advances, Vol. 6, Núm. 4, pp. 1193-1206
-
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, Núm. 8, pp. 635-642
2021
-
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
Leukemia Research, Vol. 109
-
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 10, pp. e801-e809
2020
-
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
Cancer Medicine, Vol. 9, Núm. 7, pp. 2317-2329
-
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia
Haematologica
2019
-
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
Neurotherapeutics, Vol. 16, Núm. 4, pp. 1167-1182
2018
-
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival
Leukemia and Lymphoma, Vol. 59, Núm. 10, pp. 2383-2393
2017
-
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid
Annals of hematology, Vol. 96, Núm. 7, pp. 1069-1075
-
Further psychometric validation of the GAH scale: Responsiveness and effect size
Journal of Geriatric Oncology, Vol. 8, Núm. 3, pp. 211-215
2015
-
Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale
Journal of Geriatric Oncology, Vol. 6, Núm. 5, pp. 353-361
-
Plerixafor in patients with lymphoma and multiple myeloma: Effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization
Bone Marrow Transplantation, Vol. 50, Núm. 1, pp. 34-39
2014
-
Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
Human Molecular Genetics, Vol. 23, Núm. 14, pp. 3716-3732
2009
-
Efficacy and safety of Liposomal cytarabine in lymphoma Patients with central nervous system involvement from lymphoma
Cancer, Vol. 115, Núm. 9, pp. 1892-1898
2008
-
Qualitative evaluation and suggestions for improvement of the WHO Palliative Care Demonstration Programme in Catalonia at 15 years after implementation
Medicina Paliativa, Vol. 15, Núm. 5, pp. 293-300
-
Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model
Journal of Gene Medicine, Vol. 10, Núm. 9, pp. 951-964
1993
-
CD23 expression on B-lymphocytes and its modulation by cytokines in allergic patients
Clinical and Experimental Allergy, Vol. 23, Núm. 7, pp. 612-617
-
IgE antibodies against bovine serum albumin in a case of eosinophilic gastroenteritis
Allergy, Vol. 48, Núm. 7, pp. 542-546